XTX Topco’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$277K Buy
+121,899
New +$277K 0.01% 1492
2025
Q1
Sell
-32,922
Closed -$33.9K 2526
2024
Q4
$33.9K Sell
32,922
-10,742
-25% -$11.1K ﹤0.01% 1953
2024
Q3
$51.5K Sell
43,664
-16,922
-28% -$20K ﹤0.01% 1685
2024
Q2
$73.9K Buy
60,586
+48,033
+383% +$58.6K 0.01% 1458
2024
Q1
$27.4K Sell
12,553
-7,720
-38% -$16.8K ﹤0.01% 1571
2023
Q4
$31.4K Buy
+20,273
New +$31.4K 0.01% 1300
2023
Q2
Sell
-17,815
Closed -$26.9K 1482
2023
Q1
$26.9K Sell
17,815
-11,762
-40% -$17.8K 0.01% 1201
2022
Q4
$47.3K Sell
29,577
-15,271
-34% -$24.4K 0.01% 1046
2022
Q3
$65K Sell
44,848
-55,756
-55% -$80.8K 0.02% 1002
2022
Q2
$184K Sell
100,604
-17,735
-15% -$32.4K 0.08% 486
2022
Q1
$316K Buy
118,339
+108,174
+1,064% +$289K 0.14% 250
2021
Q4
$44K Buy
+10,165
New +$44K 0.02% 578
2021
Q3
Sell
-21,422
Closed -$136K 748
2021
Q2
$136K Buy
+21,422
New +$136K 0.05% 623